Innate Pharma SA (IPHA)
3.02
+1.47
(+94.84%)
USD |
NASDAQ |
Dec 13, 16:00
2.46
-0.56
(-18.54%)
After-Hours: 07:38
Innate Pharma Market Cap: 244.47M for Dec. 13, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 73.24M |
| Cellectis SA | 176.17M |
| Genfit SA | 190.64M |
| Inventiva SA | 128.29M |
| Nanobiotix SA | 157.86M |
Market Cap Related Metrics
| PS Ratio | 9.111 |
| PEG Ratio | -0.1734 |
| Price to Book Value | 7.920 |
| Price | 3.02 |
| Earnings Yield | -14.98% |
| PEGY Ratio | -0.1734 |